Estrogen Linked to Lowered Immunity in FishJune 04, 2009Exposure to estrogen reduces production of immune-related proteins in fish. This suggests that certain compounds, known as endocrine disruptors, may make fish more susceptible to disease. The research may provide new clues for why intersex fish, fish kills and fish lesions often occur together in the Shenandoah and Potomac rivers. The tests were conducted in a lab by scientists from the U.S. Geological Survey. The study, led by USGS genomics researcher Dr. Laura Robertson, revealed that largemouth bass injected with estrogen produced lowered levels of hepcidin, an important iron-regulating hormone in mammals that is also found in fish and amphibians. This is the first published study demonstrating control of hepcidin by estrogen in any animal. Besides being an important iron-regulating hormone, researchers also suspect that hepcidin may act as an antimicrobial peptide in mammals, fish and frogs. Antimicrobial peptides are the first line of defense against disease-causing bacteria and some fungi and viruses in vertebrate animals. "Our research suggests that estrogen-mimicking compounds may make fish more susceptible to disease by blocking production of hepcidin and other immune-related proteins that help protect fish against disease-causing bacteria," said Robertson. USGS researchers Drs. Vicki Blazer and Luke Iwanowicz have previously found intersex occurring in fish in the Potomac and Shenandoah rivers. Intersex is primarily revealed in male fish that have immature female egg cells in their testes. Because other studies have shown that estrogen and estrogen-mimicking compounds can cause intersex, the co-occurrence of fish lesions, fish kills and intersex in these two rivers suggested to USGS scientists that estrogen-mimicking compounds could be involved in the fish lesions and fish kills in addition to being a possible cause of intersex traits. That caused Robertson and her colleagues to investigate how estrogen could be affecting the immune system in these fish. The study showed that largemouth bass produced two different hepcidin proteins. Production of the first hepcidin protein was "turned down" by estrogen. Production of the second hepcidin protein by fish exposed to bacteria was blocked by estrogen. The fact that estrogen blocked production of hepcidins in fish exposed to bacteria gives more weight to the theory that estrogen or estrogen-mimicking chemicals could be making fish more susceptible to diseases, Robertson added. Hepcidin could protect against bacterial infection in two ways. "First," said Robertson, "hepcidin could be an antimicrobial peptide that actually kills pathogens. Or it could be more complex. To live, a microbe must have iron, so when a microbe invades a person or animal, that microbe must obtain iron from its host. To 'fight' the microbe, a host can 'suck up iron' and store it in places inaccessible to the microbe. In mammals, hepcidin is a key player in how the host takes up and stores iron." The study, Identification of centrarchid hepcidins and evidence that 17β-estradiol disrupts constitutive expression of hepcidin-1 and inducible expression of hepcidin-2 in largemouth bass (Micropterus salmoides), was just published in the journal, Fish & Shellfish Immunology. The authors are USGS scientists Laura Robertson, Luke Iwanowicz and Jamie Marie Marranca. U.S. Geological Survey |
|||||||||||||||||||||
| Related Estrogen Current Events and Estrogen News Articles Heart and bone damage from low vitamin D tied to declines in sex hormones Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Mayo researchers find robotic repair for vaginal prolapse has significant benefits New Mayo Clinic research has found that robotic surgery for vaginal prolapse dramatically reduces patient hospital stay and recovery time. Estrogen therapy likely must be given soon after menopause to provide stroke protection For estrogen replacement to provide stroke protection, it likely must be given soon after levels drop because of menopause or surgical removal of the ovaries, scientists report in the Journal of Neuroscience. Oral contraceptives may benefit women with asthma New research shows that during natural menstrual cycles, women with asthma who were not taking oral contraceptives (OC) had lower exhaled nitric oxide levels (eNO), a marker of airway inflammation associated with asthma, than women who were taking OC. Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women. Hormone mix could cut breast cancer risk and treat symptoms of menopause The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk. Breast tenderness during hormone replacement therapy linked to elevated cancer risk Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study. Study finds no relationship between PCR rate and race in women with breast cancer Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according to researchers at The University of Texas M. D. Anderson Cancer Center. More Estrogen Current Events and Estrogen News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||